Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

$3M NIH Grant Enables Baylor International HIV/AIDS Program

Published: Wednesday, February 19, 2014
Last Updated: Wednesday, February 19, 2014
Bookmark and Share
Researchers to study genetic differences of disease in sub-Saharan African children.

A $3 million, three-year grant from the National Institutes of Health will enable researchers from the Baylor International Pediatric AIDS Initiative at Texas Children’s Hospital to study the genetic factors that affect the progression of tuberculosis and HIV in one of the largest populations infected with the diseases yet to be studied– children in sub-Saharan Africa.

The grant will establish The Collaborative African Genomics Network (CAfGEN) and include collaborators from two BIPAI sites - the Botswana-Baylor Children’s Centre of Excellence and the Baylor-Uganda Children’s Clinical Center of Excellence, along with Makerere University in Uganda, the University of Botswana, and Baylor College of Medicine.  

Working to improve treatments
“Advanced genetic and genomic technologies have the promise to transform our understanding and approach to health and human diseases,” said Dr. Graeme Mardon, professor of molecular and human genetics and pathology & immunology at Baylor and principal investigator of the Baylor portion of the grant.

The team will use state-of-the-art genomic technologies to study a rare group of HIV-infected children who can control the infection for years without needing anti-retroviral therapy to prevent AIDS. They will also be following a group of HIV positive children infected with tuberculosis to identify new genes associated with disease progression.

Their ultimate goal is to offer improved diagnostics and new therapeutic avenues in tuberculosis and HIV/AIDS.

“Most of the previous genetic studies in HIV were undertaken in non-African, adult populations,” said Dr. Gabriel Anabwani, executive director of the Botswana-Baylor Children’s Center of Excellence and the lead principal investigator of the grant. “There is a great need to study the genetic factors of progression in children; their disease differs considerably from their adult counterparts and they potentially have more to gain from therapeutic advances.”

Genomic expertise
The clinical centers will provide expertise for patient recruitment while the universities will provide local molecular genetic resources. Baylor, home to one of the top-rated genetics programs in the United States, will bring to the partnership access to genomics expertise and resources that will ultimately be transitioned to African researchers and institutions through an extensive training program designed to develop highly-knowledgeable geneticists in African nations.

Other principal investigators include Drs. Oathokwa Nkomazana and Sununguko Mpoloka from the University of Botswana; Dr. Moses Joloba from Makerere University; and Dr. Adeodata Kekitiinwa from the Baylor-Uganda Children’s Clinical Center of Excellence. Other key Baylor investigators include Dr. Neil Hanchard, assistant professor of molecular and human genetics, and Dr. Chester Brown, associate professor of molecular and human genetics and of pediatrics.

The grant will also help establish core genomics facilities in Botswana and Uganda, with trainees from those institutions having the chance to work in several highly-regarded core laboratories at BCM including the Human Genome Sequencing Center, the Laboratory for Translational Genomics in the Children’s Nutrition Research Center, and the Center for Statistical Genetics.

“The excitement of this grant is not only the potential for improved care in childhood HIV, but the improvements in knowledge and infrastructure that will serve the people of Africa for many years to come,” said Kekitiinwa. 

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Antibodies Block Norovirus’ Entrance into Cells
Scientists have uncovered a mechanism in the human body that targets and successfully blocks noroviruses.
Tuesday, September 20, 2016
Growing Noroviruses in the Lab
Human noroviruses – the leading viral cause of acute diarrhea around the world – have been difficult to study because scientists had not found a way to grow them in the lab.
Tuesday, August 30, 2016
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
Tuesday, August 23, 2016
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Friday, May 20, 2016
Largest Genomic Study on Kidney Cancer
Understanding the complexity of cancer is a major goal of the scientific community, and for kidney cancer researchers this goal just got closer.
Wednesday, March 16, 2016
Largest Genomic Study on Kidney Cancer Brings Hope for More Effective Treatments
Researchers at Baylor College of Medicine have found that a pathway called immune checkpoint was most active in a subtype of clear cell kidney cancer that is typically very aggressive.
Tuesday, March 08, 2016
Baylor, DNAnexus Collaborate
Partnership sets out to develop HgV, a new iteration of HGSC's Mercury, a BCM-developed data processing and variant calling pipeline for analyzing and annotating next-generation sequencing data in research and clinical contexts.
Tuesday, June 23, 2015
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Tuesday, May 26, 2015
Role of Cancer Stem Cells in Chemo-Resistance
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancer.
Friday, December 05, 2014
Massimo Pietropaolo Named McNair Scholar at Baylor
World renowned physician-scientist in type 1 diabetes research, Dr. Massimo Pietropaolo, has been named McNair Scholar at Baylor College of Medicine.
Wednesday, October 29, 2014
Clinical Integration of NGS
Experts provide much-needed policy analysis for clinical integration of next generation sequencing.
Tuesday, September 23, 2014
Collaboration Unravels Novel Mechanism for Neurological Disorder
The novel gene (CLP1) associated with a neurological disorder affecting both the peripheral and central nervous systems.
Saturday, April 26, 2014
Baylor College of Medicine, Berry Genomics Co. Seek to Improve on Prenatal Genetic Tests
Teams aim to improve prenatal genetic testing by combining BCM’s expertise in using microarrays for DNA analysis and Berry’s non-invasive technology evaluating fetal DNA in maternal plasma.
Monday, January 07, 2013
Microarray Analysis Improves Prenatal Diagnosis
A "chip" or array that can quickly detect disorders such as Down syndrome, or other diseases associated with chromosomal abnormalities, has proved an effective tool in prenatal diagnosis in 300 cases, as reported by Baylor College of Medicine.
Tuesday, November 29, 2011
Experimental Drug Targets Chemo-Resistant Breast Cancer Stem Cells
The cells that remain after treatment that could potentially refuel tumor growth, researchers say.
Monday, December 14, 2009
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Genes Help Track Odd Migrations of Zika Mosquitoes
Study shows that mosquitoes carrying Zika virus or Dengue fever a genetically distinct around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos